| | Class 2 Device Recall EZ1 DSP Virus Kit |  |
| Date Initiated by Firm | May 28, 2018 |
| Create Date | August 02, 2018 |
| Recall Status1 |
Terminated 3 on April 05, 2019 |
| Recall Number | Z-2596-2018 |
| Recall Event ID |
80430 |
| Product Classification |
Clinical sample concentrator - Product Code JJH
|
| Product | EZ1 DSP Virus Kit (48), IVD, REF 62724 intended for in vitro diagnostic use. |
| Code Information |
UDI - 04053228000099 Lot - 160020069 Expiration - 11/01/19 |
| FEI Number |
3013155221
|
Recalling Firm/ Manufacturer |
QIAGEN 19300 GERMANTOWN RD GERMANTOWN MD 20874 USA KOELN Germany
|
Manufacturer Reason for Recall | Underfilled reagent well that could lead to incorrect results |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | On May 28, 2018 QIAGEN issued an Urgent Notice of Product Field Action and a Acknowledgement of Receipt form to customers.
Actions to be taken by the customer/user/commercial partner are as follows:
- If you have any remaining stocks, do not use them, contact our technical service for a free-of-charge replacement and dispose of the product in accordance with your national, local safety and environmental regulations.
- Review the notice with your laboratory/medical director.
- Forward the information to all individuals and departments within your organization.
- If product was further distributed, forward a copy of the notice to
the product end user.
- QIAGEN also recommends a review of the corresponding results. Consider the possibility of under-quantification and false negative results and evaluate the need for retesting with different EZ1 DSP Virus Kit lots e.g. depending on the clinical presentation and history of the patient
- Complete and return the Acknowledgement of Receipt form and email to: quality.communications@qiagen.com. |
| Quantity in Commerce | 287 pcs |
| Distribution | Domestic - MD
Internationally - AE, AU , CZ, DE, DZ, ES, FR, GB, HK , IE, IT, NO, RO & SA |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|